Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 15 | 2023 | 2942 | 1.280 |
Why?
|
| Genetic Variation | 16 | 2024 | 1582 | 1.270 |
Why?
|
| Data Curation | 2 | 2019 | 14 | 1.150 |
Why?
|
| Genome, Human | 10 | 2025 | 1330 | 1.050 |
Why?
|
| Research Personnel | 1 | 2024 | 135 | 0.810 |
Why?
|
| Genetic Testing | 12 | 2023 | 1097 | 0.720 |
Why?
|
| Genetic Association Studies | 4 | 2025 | 854 | 0.670 |
Why?
|
| Databases, Genetic | 10 | 2024 | 499 | 0.650 |
Why?
|
| Adenomatous Polyposis Coli | 3 | 2024 | 44 | 0.570 |
Why?
|
| Information Dissemination | 1 | 2019 | 199 | 0.540 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2023 | 947 | 0.500 |
Why?
|
| Genomics | 12 | 2024 | 1644 | 0.390 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 358 | 0.390 |
Why?
|
| Germ-Line Mutation | 6 | 2023 | 368 | 0.340 |
Why?
|
| Computational Biology | 6 | 2024 | 874 | 0.330 |
Why?
|
| Germ Cells | 4 | 2023 | 203 | 0.270 |
Why?
|
| Intellectual Disability | 2 | 2025 | 1093 | 0.260 |
Why?
|
| Abnormalities, Multiple | 3 | 2025 | 968 | 0.260 |
Why?
|
| Knowledge Bases | 3 | 2023 | 40 | 0.250 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2025 | 3 | 0.240 |
Why?
|
| SMARCB1 Protein | 1 | 2025 | 48 | 0.230 |
Why?
|
| Rhabdoid Tumor | 1 | 2025 | 56 | 0.230 |
Why?
|
| Neurilemmoma | 1 | 2025 | 46 | 0.230 |
Why?
|
| Micrognathism | 1 | 2025 | 67 | 0.230 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2024 | 28 | 0.230 |
Why?
|
| Hand Deformities, Congenital | 1 | 2025 | 94 | 0.220 |
Why?
|
| Social Justice | 1 | 2025 | 65 | 0.220 |
Why?
|
| Neck | 1 | 2025 | 142 | 0.220 |
Why?
|
| Humans | 37 | 2025 | 132049 | 0.210 |
Why?
|
| Face | 1 | 2025 | 189 | 0.210 |
Why?
|
| DNA Copy Number Variations | 3 | 2019 | 1034 | 0.210 |
Why?
|
| Megalencephaly | 1 | 2023 | 60 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 3355 | 0.200 |
Why?
|
| Precision Medicine | 4 | 2020 | 360 | 0.190 |
Why?
|
| Receptor, trkA | 1 | 2022 | 17 | 0.190 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2022 | 52 | 0.180 |
Why?
|
| Zebrafish | 3 | 2023 | 421 | 0.170 |
Why?
|
| Specialties, Nursing | 1 | 2020 | 4 | 0.160 |
Why?
|
| Education, Nursing, Continuing | 1 | 2020 | 18 | 0.160 |
Why?
|
| Penetrance | 1 | 2020 | 113 | 0.160 |
Why?
|
| Counselors | 1 | 2019 | 23 | 0.160 |
Why?
|
| Cadherins | 1 | 2019 | 178 | 0.150 |
Why?
|
| Medicine | 1 | 2019 | 106 | 0.140 |
Why?
|
| Data Collection | 1 | 2020 | 387 | 0.140 |
Why?
|
| Gene Frequency | 2 | 2018 | 750 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 292 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 258 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2023 | 549 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 894 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2019 | 435 | 0.140 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2016 | 15 | 0.130 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2016 | 63 | 0.130 |
Why?
|
| 5'-Nucleotidase | 1 | 2016 | 21 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 178 | 0.130 |
Why?
|
| Quality of Health Care | 1 | 2020 | 417 | 0.130 |
Why?
|
| Chromosome Breakage | 1 | 2016 | 158 | 0.120 |
Why?
|
| Wound Healing | 1 | 2020 | 480 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2018 | 494 | 0.120 |
Why?
|
| DCC Receptor | 1 | 2015 | 5 | 0.120 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 198 | 0.120 |
Why?
|
| Chromosome Breakpoints | 1 | 2015 | 83 | 0.110 |
Why?
|
| Mutation | 5 | 2025 | 6250 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2015 | 61 | 0.110 |
Why?
|
| Algorithms | 2 | 2024 | 1713 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2015 | 94 | 0.110 |
Why?
|
| Base Sequence | 3 | 2015 | 2986 | 0.110 |
Why?
|
| INDEL Mutation | 1 | 2015 | 92 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 462 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2015 | 111 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2015 | 142 | 0.110 |
Why?
|
| United States | 3 | 2025 | 11620 | 0.110 |
Why?
|
| Genomic Structural Variation | 1 | 2015 | 92 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3834 | 0.110 |
Why?
|
| PAX5 Transcription Factor | 1 | 2013 | 15 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 765 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 578 | 0.100 |
Why?
|
| Adenoma | 1 | 2015 | 143 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 458 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2016 | 402 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2019 | 1068 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 638 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 686 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 2849 | 0.090 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 146 | 0.090 |
Why?
|
| Child | 7 | 2023 | 25779 | 0.090 |
Why?
|
| Mutation, Missense | 3 | 2023 | 937 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 1205 | 0.080 |
Why?
|
| Alleles | 3 | 2018 | 1681 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1809 | 0.070 |
Why?
|
| Age Factors | 1 | 2015 | 2921 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2008 | 157 | 0.070 |
Why?
|
| Diploidy | 2 | 2020 | 39 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 306 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1595 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1826 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2684 | 0.060 |
Why?
|
| Genotype | 2 | 2025 | 2706 | 0.060 |
Why?
|
| Software | 3 | 2018 | 726 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 3977 | 0.060 |
Why?
|
| Neurofibromatoses | 1 | 2025 | 10 | 0.060 |
Why?
|
| Phenotype | 2 | 2025 | 4544 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 1410 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1394 | 0.050 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2023 | 12 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2025 | 222 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2023 | 50 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2023 | 37 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2023 | 98 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2016 | 14821 | 0.050 |
Why?
|
| Adult | 3 | 2022 | 31576 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 146 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 242 | 0.050 |
Why?
|
| Gene Fusion | 1 | 2022 | 59 | 0.050 |
Why?
|
| Female | 6 | 2020 | 70672 | 0.050 |
Why?
|
| Virulence | 1 | 2022 | 279 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 282 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 233 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 2485 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2022 | 360 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2023 | 748 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2009 | 295 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2018 | 35 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2018 | 29 | 0.040 |
Why?
|
| Male | 4 | 2020 | 64891 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 623 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2019 | 246 | 0.030 |
Why?
|
| Counseling | 1 | 2019 | 235 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2018 | 130 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2020 | 453 | 0.030 |
Why?
|
| Access to Information | 1 | 2018 | 43 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 772 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2019 | 392 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2018 | 222 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 3019 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2016 | 144 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 73 | 0.030 |
Why?
|
| Consensus | 1 | 2019 | 655 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 116 | 0.030 |
Why?
|
| Chromosomes | 1 | 2016 | 140 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 2016 | 140 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 168 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 564 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2018 | 772 | 0.030 |
Why?
|
| Mitosis | 1 | 2016 | 201 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 257 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2018 | 797 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 202 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2016 | 442 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 548 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 353 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 832 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 414 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 867 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 793 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1684 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 1171 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 542 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 513 | 0.030 |
Why?
|
| DNA Repair | 1 | 2016 | 569 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1118 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1359 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 1724 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 880 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 729 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1875 | 0.020 |
Why?
|
| Animals | 3 | 2023 | 35067 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1304 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2009 | 19 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3655 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2511 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 416 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1758 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3386 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7552 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 6509 | 0.020 |
Why?
|
| Internet | 1 | 2008 | 402 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 7097 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 1028 | 0.010 |
Why?
|
| DNA | 1 | 2008 | 1529 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13113 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6411 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 21317 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 3196 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 28827 | 0.010 |
Why?
|